Assessment of the cytotoxic mechanisms of β-sitosterol in a pancreatic cancer cell line: An in silico and in vitro study

Clicks: 1
ID: 284725
2024
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #2,906 of 3,757 articles by views in Malay Journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 3,757 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Pancreatic cancer recently observed a rise in incidence and prevalence in terms of cancer-related mortality worldwide. Although recent modifications in chemotherapy, radiation therapy, and immunotherapy provide increased options for treatment, the survival rate of pancreatic cancer compared to other types of malignancies is still relatively low. β-sitosterol has been found to show incredible potential as an anticancer compound in a variety of disease models given its ability to inhibit cell proliferation, induce apoptosis, and instigate cell cycle arrest. However, there is a limited amount of studies that investigate its activity in pancreatic cancer models. The study gives an insight on the activity of β-sitosterol in pancreatic cancer cells via assessment of the potential of soybean-derived β-sitosterol as a drug candidate through an in silico pharmacokinetic ADMET analysis and its cytotoxic capabilities. The ADMET study was able to predict that soybean-derived β-sitosterol is an ideal drug candidate based on three properties: metabolism, excretion, and toxicity. Various dosages of soybean-derived β-sitosterol (0, 5, 15, 30, 60, and 150-μM) were able to demonstrate cytototoxic outcomes after a 24-hour treatment period. The compound was found to be potent enough to induce cytotoxicity at a lower dosage based on its IC50 value of 2.685-μM. Molecular docking studies showed that AGR2 had the highest binding affinity with the ligand interacting at the A-chain of the protein through a variety of favorable non-bond interactions (i.e., hydrophobic interactions, van der Waals interactions, etc.). Through this study we hope to contribute to understanding the underlying mechanism as to how β-sitosterol interacts with pathogenic pancreatic proteins which may pave the way for the development of more effective cancer treatments.
Reference Key
persistent_1760653501_68f170bd77a61 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Serranilla, Kirsten Ysabelle V.
Journal Malay Journal
Year 2024
DOI
DOI not found
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.